Gatekeeper, caretaker, and landscaper mutations

Slides:



Advertisements
Similar presentations
Cancer—Principles and overview By Robert A. Weinberg
Advertisements

Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
Cancer: a genetic disease of inherited and somatic mutations n Gene mutations and/or genetic instability are involved in many cancers. n Viruses and environmental.
Lessons from Hereditary Colorectal Cancer
VogelsteinScience15Apr13.ppt Updated: April 15, 2013 Why Is Cancer Therapy Such a Difficult and Often Intractable Effort? Cancer Genome Landscapes. Science,
Copyright (c) by W. H. Freeman and Company Chapter 24 Cancer.
MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
What is Cancer? How it occurs and cell cycle regulation.
Cancer Deregulation of cell cycle Loss of control of mitosis Result of mutation Over 200 types of cancer exists (Number of cancer cases will double by.
ONCOLOGY THE STUDY OF CANCER What is it? How do you get it?
By the end of this lecture, students will learn: 1.What is cancer. 2.Genetics of cancer. 3.Oncogenes 4.Tumor suppressor genes. 5.DNA Repair genes 6.Genes.
Chapter 18 Regulation of Gene Expression Dr. Joseph Silver.
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section D: The.
Lecture 28 Genetics of Cancer Copyright © 2010 Pearson Education Inc.
Cancer Genome Landscapes
Cancer Cancer- a malignant tumor; the result of abnormal cell proliferation. Regulation of Cell Division –Tumor Supressor Genes Genes that inhibit cell.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
Schematic representation of mechanisms of activation of a host gene by insertion of a provirus and the general structure of leukemia and leukosis and acute.
Cell-cycle checkpoint activation downstream of ATM and ATR
Contrasting hypotheses of genomic imprinting in cancer
Spectrum of different types of human gene mutations logged in Human Gene Mutation Database as of September 13, 1998 ( Source: The.
Karyotyping Cancer.
Combinatorial interactions of cyclins and cyclin-dependent kinases (cdks) during the cell cycle. Progression from G0 through the restriction point in G1.
Mutations in the retinoblastoma tumor-suppressor gene (RB1) contribute to inherited and sporadic cancers. The figure indicates that cell context affects.
Genetic instability in epithelial tissues compared to stromal tissues
Desmoplastic small round cell tumor
Methods for site-directed mutagenesis
Angiogenic switch and progression during tumor development
Cancer – a disease of many mutations
Distribution of CpG dinucleotide in the human genome and differences in methylation patterns between normal and tumor cells. In the majority of the mammalian.
Structures of antiestrogens and aromatase inhibitors
GENETIC BASIS OF CANCER
Schematic outline of MeDIP
A representation of the DNA damage-induced cell cycle checkpoint pathway in mammalian cells. DNA damage results in accumulation of the p53 protein. Accumulation.
Sprouting angiogenesis
Contrasting hypotheses of genomic imprinting in cancer
Increasingly detailed genomic data from successive generations of DNA sequencing technology reveal the clonal structure of cancer cell populations. Early.
Outline of the process of TMA assembly
Age-standardized incidence and mortality rates across 20 years, and incidence, death and prevalence estimates for the year 2000, Canada. (Top) Age-standardized.
miRNA genomic organization, biogenesis and function
Total infralevator exenteration
PET imaging can also be applied in the preclinical setting to increase our understanding of the underlying biology, as well as inform the design of clinical.
Structure and mutation spectrum of BRCA1
Orofacial dyskinesia in a patient with Huntington's disease
Antigen-processing pathways in the APC
Cell survival curves. A) Cells are exposed either in monolayer or in suspension culture to different doses of a drug for a given time, or to a single dose.
The processing of microRNA that is involved in gene regulation by RNA interference. (Reprinted with permission from Brooker RJ: Genetics: Analysis & Principles,
p53 function and regulation in normal cells and cancer cells
Electrophoregram profiles showing the 35delG mutation of CX26 (GJB2) in an individual with recessively inherited hearing loss, and in his heterozygous.
Targeting signal transduction
Basic algorithm for cancer risk assessment that employs gene testing.
Compound heterozygosity at two different loci in hereditary hearing loss. (a) Autosomal recessive hearing loss due to mutations in the gene connexin 26.
Structure and mutation spectrum of BRCA2
CANCER.
Cancer.
The Cell Cycle and Cancer
Patient VB Li-Fraumeni Syndrome.
Cancer.
Genetics of Cancer.
Mutations and Genetic Abnormalities
BIOLOGY 12 Cancer.
Hallmarks of Cancer Covered
Cancer.
Volume 26, Issue 1, Pages 1-2 (July 2014)
Volume 13, Issue 1, Pages 1-2 (January 2008)
Cell Cycle Regulation Chapter 9 Section 3.
The Dual Role of Bone Morphogenetic Proteins in Cancer
Aida Di Gregorio, Sarah Bowling, Tristan Argeo Rodriguez 
Specific Tumor Suppressor Genes
Presentation transcript:

Gatekeeper, caretaker, and landscaper mutations Gatekeeper, caretaker, and landscaper mutations. In the late 1990s, Kenneth Kinzler and Bert Vogelstein proposed a model of tumorigenesis based on their observations of the oncogenic mechanisms underlying hereditary colorectal cancer. Tumor-promoting genes were classified as gatekeepers, caretakers, and landscapers, according to their function. Gatekeeper genes encode proteins that regulate cell fate, be it proliferation, growth, arrest, death, or differentiation. Because deregulation of these mechanisms is likely to lead directly to abnormal growth, mutations in these genes correlate with the highest risk of cancer. Caretaker genes encode proteins that are responsible for guarding the integrity of the genome, with loss of function increasing the risk of acquiring mutations, for instance, in gatekeeper genes, that would lead to oncogenic growth. Mutations occurring in cells of the surrounding tissue stroma can create a microenvironment that is more permissive for tumorigenesis, and the associated genes were categorized as landscapers. As the functions of these genes are primarily supportive, in isolation, these mutations are much less penetrant. Source: Oncogenes and Tumor-Suppressor Genes, The Basic Science of Oncology, 5e Citation: Tannock IF, Hill RP, Bristow RG, Harrington L. The Basic Science of Oncology, 5e; 2016 Available at: http://hemonc.mhmedical.com/DownloadImage.aspx?image=/data/books/1791/tanbas5_ach7_f005.png&sec=124303832&BookID=1791&ChapterSecID=124303803&imagename= Accessed: November 01, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved